

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 9.42768304 |
| 2 | positive thymic T cell selection (GO:0045059) | 9.07250415 |
| 3 | negative T cell selection (GO:0043383) | 8.93827951 |
| 4 | positive T cell selection (GO:0043368) | 8.58266822 |
| 5 | negative thymic T cell selection (GO:0045060) | 8.43950113 |
| 6 | cytidine deamination (GO:0009972) | 8.05959637 |
| 7 | cytidine metabolic process (GO:0046087) | 8.05959637 |
| 8 | cytidine catabolic process (GO:0006216) | 8.05959637 |
| 9 | thymic T cell selection (GO:0045061) | 7.99537860 |
| 10 | positive regulation of gamma-delta T cell activation (GO:0046645) | 7.75071760 |
| 11 | interferon-gamma production (GO:0032609) | 7.44900881 |
| 12 | pyrimidine ribonucleoside catabolic process (GO:0046133) | 7.38754434 |
| 13 | T cell selection (GO:0045058) | 7.26941714 |
| 14 | regulation of single stranded viral RNA replication via double stranded DNA intermediate (GO:0045091 | 7.10772775 |
| 15 | DNA deamination (GO:0045006) | 6.90881397 |
| 16 | regulation of gamma-delta T cell differentiation (GO:0045586) | 6.66249434 |
| 17 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 6.52636862 |
| 18 | negative regulation of cell killing (GO:0031342) | 6.52636862 |
| 19 | regulation of isotype switching to IgG isotypes (GO:0048302) | 6.46698084 |
| 20 | * T cell receptor signaling pathway (GO:0050852) | 6.37629111 |
| 21 | regulation of T cell receptor signaling pathway (GO:0050856) | 6.32587376 |
| 22 | cellular response to interleukin-15 (GO:0071350) | 6.29582790 |
| 23 | regulation of T cell tolerance induction (GO:0002664) | 6.19443605 |
| 24 | regulation of gamma-delta T cell activation (GO:0046643) | 5.98996754 |
| 25 | leukocyte aggregation (GO:0070486) | 5.91662907 |
| 26 | response to interleukin-15 (GO:0070672) | 5.89229227 |
| 27 | regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 5.64454199 |
| 28 | * T cell costimulation (GO:0031295) | 5.57537398 |
| 29 | * lymphocyte costimulation (GO:0031294) | 5.52509946 |
| 30 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 5.42865175 |
| 31 | T cell migration (GO:0072678) | 5.39047691 |
| 32 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 5.27038046 |
| 33 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 5.27038046 |
| 34 | * antigen receptor-mediated signaling pathway (GO:0050851) | 5.25858901 |
| 35 | positive regulation of tolerance induction (GO:0002645) | 5.07791220 |
| 36 | regulation of B cell receptor signaling pathway (GO:0050855) | 5.00411086 |
| 37 | positive regulation of alpha-beta T cell proliferation (GO:0046641) | 4.92126171 |
| 38 | negative regulation of T cell mediated immunity (GO:0002710) | 4.69343152 |
| 39 | sequestering of actin monomers (GO:0042989) | 4.69060943 |
| 40 | regulation of alpha-beta T cell proliferation (GO:0046640) | 4.67933289 |
| 41 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 4.66917686 |
| 42 | mast cell activation (GO:0045576) | 4.61691161 |
| 43 | positive regulation of natural killer cell mediated cytotoxicity (GO:0045954) | 4.41699588 |
| 44 | positive regulation of natural killer cell mediated immunity (GO:0002717) | 4.41699588 |
| 45 | regulation of tolerance induction (GO:0002643) | 4.39313183 |
| 46 | antigen processing and presentation of endogenous antigen (GO:0019883) | 4.34074351 |
| 47 | positive regulation of calcium-mediated signaling (GO:0050850) | 4.24904564 |
| 48 | regulation of natural killer cell mediated immunity (GO:0002715) | 4.20923067 |
| 49 | regulation of natural killer cell mediated cytotoxicity (GO:0042269) | 4.20923067 |
| 50 | positive regulation of B cell differentiation (GO:0045579) | 4.20348923 |
| 51 | negative regulation of T cell apoptotic process (GO:0070233) | 4.20132129 |
| 52 | negative regulation of T cell receptor signaling pathway (GO:0050860) | 4.17574275 |
| 53 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 4.17333469 |
| 54 | regulation of B cell differentiation (GO:0045577) | 4.10228453 |
| 55 | regulation of interleukin-2 biosynthetic process (GO:0045076) | 4.08539448 |
| 56 | positive regulation of B cell mediated immunity (GO:0002714) | 4.05875343 |
| 57 | positive regulation of immunoglobulin mediated immune response (GO:0002891) | 4.05875343 |
| 58 | negative regulation of viral genome replication (GO:0045071) | 4.05170477 |
| 59 | negative regulation by host of viral transcription (GO:0043922) | 4.04847410 |
| 60 | positive regulation of leukocyte mediated cytotoxicity (GO:0001912) | 4.03999772 |
| 61 | T cell differentiation (GO:0030217) | 3.98934815 |
| 62 | regulation of immunoglobulin mediated immune response (GO:0002889) | 3.98392911 |
| 63 | positive regulation of isotype switching (GO:0045830) | 3.97853606 |
| 64 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 3.96586669 |
| 65 | tolerance induction (GO:0002507) | 3.96466283 |
| 66 | regulation of leukocyte mediated cytotoxicity (GO:0001910) | 3.89739935 |
| 67 | negative regulation of antigen receptor-mediated signaling pathway (GO:0050858) | 3.89570523 |
| 68 | regulation of isotype switching (GO:0045191) | 3.85097300 |
| 69 | regulation of B cell mediated immunity (GO:0002712) | 3.83173156 |
| 70 | positive regulation of defense response to virus by host (GO:0002230) | 3.76517689 |
| 71 | negative regulation of lipopolysaccharide-mediated signaling pathway (GO:0031665) | 3.76090838 |
| 72 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 3.75933047 |
| 73 | activated T cell proliferation (GO:0050798) | 3.74566717 |
| 74 | positive regulation of cell killing (GO:0031343) | 3.71107241 |
| 75 | positive regulation of granulocyte differentiation (GO:0030854) | 3.63184324 |
| 76 | pyrimidine nucleoside catabolic process (GO:0046135) | 3.62872968 |
| 77 | cellular defense response (GO:0006968) | 3.62388640 |
| 78 | positive regulation of interleukin-8 secretion (GO:2000484) | 3.61641730 |
| 79 | regulation of cell killing (GO:0031341) | 3.58650262 |
| 80 | * immune response-activating cell surface receptor signaling pathway (GO:0002429) | 3.56522899 |
| 81 | positive regulation of interleukin-2 production (GO:0032743) | 3.56175162 |
| 82 | regulation of response to interferon-gamma (GO:0060330) | 3.55858512 |
| 83 | regulation of lymphocyte chemotaxis (GO:1901623) | 3.55650709 |
| 84 | * T cell activation (GO:0042110) | 3.53705161 |
| 85 | regulation of regulatory T cell differentiation (GO:0045589) | 3.52434464 |
| 86 | regulation of T cell mediated cytotoxicity (GO:0001914) | 3.50732887 |
| 87 | regulation of interferon-gamma-mediated signaling pathway (GO:0060334) | 3.50653385 |
| 88 | regulation of chronic inflammatory response (GO:0002676) | 3.50557368 |
| 89 | positive regulation of DNA recombination (GO:0045911) | 3.49842077 |
| 90 | natural killer cell activation (GO:0030101) | 3.47518927 |
| 91 | regulation of immunoglobulin production (GO:0002637) | 3.46383593 |
| 92 | alpha-beta T cell differentiation (GO:0046632) | 3.45314601 |
| 93 | lymphocyte migration (GO:0072676) | 3.43464390 |
| 94 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 3.43139176 |
| 95 | positive regulation of immunoglobulin production (GO:0002639) | 3.42850937 |
| 96 | antigen processing and presentation via MHC class Ib (GO:0002475) | 3.42593294 |
| 97 | negative regulation of B cell proliferation (GO:0030889) | 3.41393131 |
| 98 | leukocyte cell-cell adhesion (GO:0007159) | 3.39366544 |
| 99 | regulation of hypersensitivity (GO:0002883) | 3.39318877 |
| 100 | chemokine-mediated signaling pathway (GO:0070098) | 3.38484729 |
| 101 | mast cell activation involved in immune response (GO:0002279) | 3.36408463 |
| 102 | mast cell degranulation (GO:0043303) | 3.36408463 |
| 103 | regulation of activation of Janus kinase activity (GO:0010533) | 3.35970714 |
| 104 | positive regulation of T cell chemotaxis (GO:0010820) | 3.34734108 |
| 105 | regulation of T cell chemotaxis (GO:0010819) | 3.34734108 |
| 106 | positive regulation of interleukin-4 production (GO:0032753) | 3.34105579 |
| 107 | regulation of defense response to virus by virus (GO:0050690) | 3.32540309 |
| 108 | actin nucleation (GO:0045010) | 3.32482154 |
| 109 | heterotypic cell-cell adhesion (GO:0034113) | 3.32090215 |
| 110 | dendritic cell chemotaxis (GO:0002407) | 3.31738004 |
| 111 | V(D)J recombination (GO:0033151) | 3.31124563 |
| 112 | alpha-beta T cell activation (GO:0046631) | 3.30606684 |
| 113 | positive regulation of T cell mediated cytotoxicity (GO:0001916) | 3.23374423 |
| 114 | regulation of interleukin-4 production (GO:0032673) | 3.22350264 |
| 115 | * positive regulation of T cell activation (GO:0050870) | 3.22123332 |
| 116 | lymphocyte chemotaxis (GO:0048247) | 3.20779612 |
| 117 | regulation of viral genome replication (GO:0045069) | 3.20306468 |
| 118 | positive regulation of lamellipodium assembly (GO:0010592) | 3.20025637 |
| 119 | regulation of lymphocyte mediated immunity (GO:0002706) | 3.16629020 |
| 120 | cellular response to interleukin-4 (GO:0071353) | 3.15527261 |
| 121 | regulation of type I interferon-mediated signaling pathway (GO:0060338) | 3.14427568 |
| 122 | negative regulation of adaptive immune response based on somatic recombination of immune receptors b | 3.14015650 |
| 123 | positive regulation of macrophage differentiation (GO:0045651) | 3.11927661 |
| 124 | positive regulation of lymphocyte mediated immunity (GO:0002708) | 3.11868337 |
| 125 | negative regulation of B cell activation (GO:0050869) | 3.11773860 |
| 126 | B cell receptor signaling pathway (GO:0050853) | 3.10775385 |
| 127 | positive regulation of interleukin-1 beta secretion (GO:0050718) | 3.08846407 |
| 128 | positive regulation of lymphocyte migration (GO:2000403) | 3.08679552 |
| 129 | * regulation of T cell activation (GO:0050863) | 3.07212487 |
| 130 | regulation of interleukin-1 beta secretion (GO:0050706) | 3.06959664 |
| 131 | positive regulation of humoral immune response (GO:0002922) | 3.05642999 |
| 132 | regulation of calcium-mediated signaling (GO:0050848) | 3.05151314 |
| 133 | cellular response to type I interferon (GO:0071357) | 3.03036077 |
| 134 | type I interferon signaling pathway (GO:0060337) | 3.03036077 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 8.70423810 |
| 2 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 6.68251611 |
| 3 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 4.08951918 |
| 4 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 4.06028863 |
| 5 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 3.96381673 |
| 6 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 3.74587642 |
| 7 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 3.72562503 |
| 8 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 3.67867490 |
| 9 | RUNX_20019798_ChIP-Seq_JUKART_Human | 3.59798752 |
| 10 | MYB_26560356_Chip-Seq_TH2_Human | 3.47702592 |
| 11 | MYC_22102868_ChIP-Seq_BL_Human | 3.33834692 |
| 12 | E2F7_22180533_ChIP-Seq_HELA_Human | 3.18671900 |
| 13 | MAF_26560356_Chip-Seq_TH1_Human | 3.09723717 |
| 14 | UTX_26944678_Chip-Seq_JUKART_Human | 3.02790786 |
| 15 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.90627063 |
| 16 | MYB_26560356_Chip-Seq_TH1_Human | 2.85556235 |
| 17 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.73585899 |
| 18 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.73386142 |
| 19 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 2.52403904 |
| 20 | GATA3_27048872_Chip-Seq_THYMUS_Human | 2.27605761 |
| 21 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 2.17663455 |
| 22 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 2.14101761 |
| 23 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 2.08594254 |
| 24 | * MAF_26560356_Chip-Seq_TH2_Human | 2.04210763 |
| 25 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 2.02788226 |
| 26 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.98609413 |
| 27 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.88186138 |
| 28 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.86500024 |
| 29 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.85065718 |
| 30 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.83068009 |
| 31 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.78102646 |
| 32 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.75899940 |
| 33 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.73647255 |
| 34 | VDR_22108803_ChIP-Seq_LS180_Human | 1.72258850 |
| 35 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.71860861 |
| 36 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.71302301 |
| 37 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.66192818 |
| 38 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.65719416 |
| 39 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.61281037 |
| 40 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 1.59031038 |
| 41 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.56970665 |
| 42 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.56945172 |
| 43 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.52301582 |
| 44 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.50416870 |
| 45 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 1.48733210 |
| 46 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.42862174 |
| 47 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.41852085 |
| 48 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 1.36827983 |
| 49 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.36169736 |
| 50 | TAL1_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.33299720 |
| 51 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.32479474 |
| 52 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.32011058 |
| 53 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.31575250 |
| 54 | VDR_23849224_ChIP-Seq_CD4+_Human | 1.30560969 |
| 55 | GATA3_26560356_Chip-Seq_TH2_Human | 1.30249631 |
| 56 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.29977985 |
| 57 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.29612621 |
| 58 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.26439638 |
| 59 | GATA3_26560356_Chip-Seq_TH1_Human | 1.20858950 |
| 60 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.20539055 |
| 61 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.20515346 |
| 62 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 1.17834120 |
| 63 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.13851228 |
| 64 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.13372842 |
| 65 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.11818188 |
| 66 | * RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.11437773 |
| 67 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.11084841 |
| 68 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.10269882 |
| 69 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.09938980 |
| 70 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.09842119 |
| 71 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.06309698 |
| 72 | SPI1_23127762_ChIP-Seq_K562_Human | 1.04852760 |
| 73 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 1.04446537 |
| 74 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.03839862 |
| 75 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.02801396 |
| 76 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.01641181 |
| 77 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.01537241 |
| 78 | GATA1_22025678_ChIP-Seq_K562_Human | 0.98790271 |
| 79 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 0.98678560 |
| 80 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.98629625 |
| 81 | CIITA_25753668_ChIP-Seq_RAJI_Human | 0.97204316 |
| 82 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.95609013 |
| 83 | * LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.95537173 |
| 84 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 0.95186838 |
| 85 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 0.94922743 |
| 86 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.94438984 |
| 87 | IGF1R_20145208_ChIP-Seq_DFB_Human | 0.93924901 |
| 88 | ER_23166858_ChIP-Seq_MCF-7_Human | 0.93168351 |
| 89 | TCF12/HEB_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.92482819 |
| 90 | GATA3_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.91914427 |
| 91 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 0.91801486 |
| 92 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 0.91415201 |
| 93 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 0.90837785 |
| 94 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 0.90336056 |
| 95 | SMRT_27268052_Chip-Seq_Bcells_Human | 0.88482562 |
| 96 | VDR_24787735_ChIP-Seq_THP-1_Human | 0.88431944 |
| 97 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 0.87311210 |
| 98 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 0.85489634 |
| 99 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 0.85209006 |
| 100 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 0.84851004 |
| 101 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 0.84281980 |
| 102 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 0.82507742 |
| 103 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.82012294 |
| 104 | ELK1_19687146_ChIP-ChIP_HELA_Human | 0.80949858 |
| 105 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 0.80662788 |
| 106 | SOX11_23321250_ChIP-ChIP_Z138-A519-JVM2_Human | 0.80101589 |
| 107 | SOX6_21985497_ChIP-Seq_MYOTUBES_Mouse | 0.80076490 |
| 108 | FLI1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.79402171 |
| 109 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.79007926 |
| 110 | FOXA1_27270436_Chip-Seq_PROSTATE_Human | 0.78504309 |
| 111 | FOXA1_25329375_ChIP-Seq_VCAP_Human | 0.78504309 |
| 112 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 0.77939924 |
| 113 | GATA6_21074721_ChIP-Seq_CACO-2_Mouse | 0.76325204 |
| 114 | PAX6_23342162_ChIP-ChIP_BETA-FORBRAIN-LENS_Mouse | 0.75671499 |
| 115 | RUNX1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.75506684 |
| 116 | FLI1_21867929_ChIP-Seq_CD8_Mouse | 0.75258945 |
| 117 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 0.75210236 |
| 118 | OCT4_21477851_ChIP-Seq_ESCs_Mouse | 0.75044367 |
| 119 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 0.74410944 |
| 120 | GATA6_21074721_ChIP-Seq_CACO-2_Human | 0.73433724 |
| 121 | RUNX1_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.73024312 |
| 122 | * RBPJ_21746931_ChIP-Seq_IB4-LCL_Human | 0.72421545 |
| 123 | EBNA2_21746931_ChIP-Seq_IB4-LCL_Human | 0.72140425 |
| 124 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.71904168 |
| 125 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.71604232 |
| 126 | NANOG_20526341_ChIP-Seq_ESCs_Human | 0.71292494 |
| 127 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 0.70895362 |
| 128 | TP53_22573176_ChIP-Seq_HFKS_Human | 0.70878045 |
| 129 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 0.70280372 |
| 130 | FOXA1_21572438_ChIP-Seq_LNCaP_Human | 0.70176135 |
| 131 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.70120371 |
| 132 | FOXH1_21741376_ChIP-Seq_EPCs_Human | 0.70091410 |
| 133 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 0.69373542 |
| 134 | BCL6_27268052_Chip-Seq_Bcells_Human | 0.68817670 |
| 135 | TAF2_19829295_ChIP-Seq_ESCs_Human | 0.68024642 |
| 136 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 0.66724214 |
| 137 | XRN2_22483619_ChIP-Seq_HELA_Human | 0.66640340 |
| 138 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 0.65570371 |
| 139 | * SMAD_19615063_ChIP-ChIP_OVARY_Human | 0.65305205 |
| 140 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.63737842 |
| 141 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.63463260 |
| 142 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 0.62896795 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003763_abnormal_thymus_physiology | 6.46071108 |
| 2 | MP0005671_abnormal_response_to | 5.07669246 |
| 3 | MP0002166_altered_tumor_susceptibility | 3.81264027 |
| 4 | MP0000685_abnormal_immune_system | 3.52085483 |
| 5 | MP0002006_tumorigenesis | 3.37957327 |
| 6 | MP0001835_abnormal_antigen_presentation | 3.18587779 |
| 7 | MP0009785_altered_susceptibility_to | 3.00389466 |
| 8 | MP0001800_abnormal_humoral_immune | 2.99157494 |
| 9 | MP0005000_abnormal_immune_tolerance | 2.90719019 |
| 10 | MP0009333_abnormal_splenocyte_physiolog | 2.89963467 |
| 11 | * MP0000703_abnormal_thymus_morphology | 2.89710299 |
| 12 | * MP0002398_abnormal_bone_marrow | 2.84642116 |
| 13 | MP0006082_CNS_inflammation | 2.81186566 |
| 14 | * MP0002420_abnormal_adaptive_immunity | 2.76116305 |
| 15 | * MP0001819_abnormal_immune_cell | 2.75001122 |
| 16 | MP0002723_abnormal_immune_serum | 2.73134818 |
| 17 | MP0004381_abnormal_hair_follicle | 2.68701142 |
| 18 | MP0001790_abnormal_immune_system | 2.65764731 |
| 19 | MP0005387_immune_system_phenotype | 2.65764731 |
| 20 | MP0002009_preneoplasia | 2.58596117 |
| 21 | MP0003724_increased_susceptibility_to | 2.58303252 |
| 22 | MP0004947_skin_inflammation | 2.57484496 |
| 23 | MP0001873_stomach_inflammation | 2.51357162 |
| 24 | MP0002405_respiratory_system_inflammati | 2.47936361 |
| 25 | * MP0000716_abnormal_immune_system | 2.43458499 |
| 26 | * MP0002722_abnormal_immune_system | 2.43276727 |
| 27 | * MP0005025_abnormal_response_to | 2.43152063 |
| 28 | MP0002452_abnormal_antigen_presenting | 2.37563026 |
| 29 | MP0002933_joint_inflammation | 2.17288145 |
| 30 | MP0003866_abnormal_defecation | 2.14404152 |
| 31 | * MP0000689_abnormal_spleen_morphology | 2.14138139 |
| 32 | MP0010155_abnormal_intestine_physiology | 2.03340386 |
| 33 | MP0003300_gastrointestinal_ulcer | 1.99530244 |
| 34 | * MP0002429_abnormal_blood_cell | 1.92840701 |
| 35 | MP0002148_abnormal_hypersensitivity_rea | 1.90945899 |
| 36 | MP0002396_abnormal_hematopoietic_system | 1.85395777 |
| 37 | MP0005310_abnormal_salivary_gland | 1.76697340 |
| 38 | MP0003436_decreased_susceptibility_to | 1.68695905 |
| 39 | MP0000858_altered_metastatic_potential | 1.60305131 |
| 40 | MP0002419_abnormal_innate_immunity | 1.56432796 |
| 41 | MP0001845_abnormal_inflammatory_respons | 1.55099312 |
| 42 | MP0005464_abnormal_platelet_physiology | 1.50988435 |
| 43 | MP0001851_eye_inflammation | 1.50535300 |
| 44 | MP0002132_abnormal_respiratory_system | 1.45132067 |
| 45 | MP0004510_myositis | 1.43085144 |
| 46 | MP0001853_heart_inflammation | 1.41662819 |
| 47 | MP0002163_abnormal_gland_morphology | 1.41237956 |
| 48 | MP0002277_abnormal_respiratory_mucosa | 1.36947219 |
| 49 | MP0003448_altered_tumor_morphology | 1.32661109 |
| 50 | MP0001919_abnormal_reproductive_system | 1.31168184 |
| 51 | MP0000490_abnormal_crypts_of | 1.18120723 |
| 52 | MP0005075_abnormal_melanosome_morpholog | 1.18021887 |
| 53 | MP0002019_abnormal_tumor_incidence | 1.12158098 |
| 54 | MP0008469_abnormal_protein_level | 1.02589091 |
| 55 | MP0000569_abnormal_digit_pigmentation | 0.98697955 |
| 56 | MP0002876_abnormal_thyroid_physiology | 0.96176481 |
| 57 | MP0001348_abnormal_lacrimal_gland | 0.90330988 |
| 58 | MP0010234_abnormal_vibrissa_follicle | 0.88208826 |
| 59 | MP0003786_premature_aging | 0.86929279 |
| 60 | MP0008872_abnormal_physiological_respon | 0.86625515 |
| 61 | MP0010352_gastrointestinal_tract_polyps | 0.84035295 |
| 62 | MP0005645_abnormal_hypothalamus_physiol | 0.83922091 |
| 63 | MP0005023_abnormal_wound_healing | 0.82842111 |
| 64 | MP0004808_abnormal_hematopoietic_stem | 0.82394244 |
| 65 | MP0003303_peritoneal_inflammation | 0.82331880 |
| 66 | MP0000465_gastrointestinal_hemorrhage | 0.80919138 |
| 67 | MP0001533_abnormal_skeleton_physiology | 0.79522141 |
| 68 | MP0005389_reproductive_system_phenotype | 0.78191944 |
| 69 | MP0009763_increased_sensitivity_to | 0.77291333 |
| 70 | MP0002638_abnormal_pupillary_reflex | 0.75784895 |
| 71 | MP0002998_abnormal_bone_remodeling | 0.73725410 |
| 72 | MP0003252_abnormal_bile_duct | 0.69795397 |
| 73 | MP0000477_abnormal_intestine_morphology | 0.68876040 |
| 74 | MP0001243_abnormal_dermal_layer | 0.67298760 |
| 75 | MP0001765_abnormal_ion_homeostasis | 0.65926816 |
| 76 | MP0001501_abnormal_sleep_pattern | 0.63142079 |
| 77 | MP0000015_abnormal_ear_pigmentation | 0.61843718 |
| 78 | MP0009765_abnormal_xenobiotic_induced | 0.61537704 |
| 79 | MP0001216_abnormal_epidermal_layer | 0.61064607 |
| 80 | MP0010094_abnormal_chromosome_stability | 0.59599985 |
| 81 | MP0005670_abnormal_white_adipose | 0.59308732 |
| 82 | MP0009764_decreased_sensitivity_to | 0.59097828 |
| 83 | MP0003045_fibrosis | 0.58311470 |
| 84 | MP0002693_abnormal_pancreas_physiology | 0.57846153 |
| 85 | MP0003693_abnormal_embryo_hatching | 0.57262805 |
| 86 | MP0004130_abnormal_muscle_cell | 0.57158650 |
| 87 | MP0000627_abnormal_mammary_gland | 0.57141303 |
| 88 | MP0008057_abnormal_DNA_replication | 0.56823001 |
| 89 | MP0000609_abnormal_liver_physiology | 0.56494310 |
| 90 | MP0003453_abnormal_keratinocyte_physiol | 0.56461003 |
| 91 | MP0005451_abnormal_body_composition | 0.56045683 |
| 92 | MP0001986_abnormal_taste_sensitivity | 0.55950861 |
| 93 | MP0001191_abnormal_skin_condition | 0.55236834 |
| 94 | MP0002098_abnormal_vibrissa_morphology | 0.55092597 |
| 95 | MP0002136_abnormal_kidney_physiology | 0.54885824 |
| 96 | MP0000367_abnormal_coat/_hair | 0.54441855 |
| 97 | MP0001545_abnormal_hematopoietic_system | 0.54350183 |
| 98 | MP0005397_hematopoietic_system_phenotyp | 0.54350183 |
| 99 | MP0001881_abnormal_mammary_gland | 0.54190832 |
| 100 | MP0003787_abnormal_imprinting | 0.53082698 |
| 101 | MP0002102_abnormal_ear_morphology | 0.52891958 |
| 102 | MP0005174_abnormal_tail_pigmentation | 0.52239371 |
| 103 | MP0002138_abnormal_hepatobiliary_system | 0.50375437 |
| 104 | MP0006072_abnormal_retinal_apoptosis | 0.49766699 |
| 105 | MP0004957_abnormal_blastocyst_morpholog | 0.49690397 |
| 106 | MP0000372_irregular_coat_pigmentation | 0.49341462 |
| 107 | MP0009643_abnormal_urine_homeostasis | 0.48780922 |
| 108 | MP0008961_abnormal_basal_metabolism | 0.48543450 |
| 109 | MP0001905_abnormal_dopamine_level | 0.47014985 |
| 110 | MP0003077_abnormal_cell_cycle | 0.46537498 |
| 111 | MP0003795_abnormal_bone_structure | 0.46312058 |
| 112 | MP0002822_catalepsy | 0.45644983 |
| 113 | MP0003646_muscle_fatigue | 0.44174711 |
| 114 | MP0004134_abnormal_chest_morphology | 0.43845235 |
| 115 | MP0005551_abnormal_eye_electrophysiolog | 0.42869027 |
| 116 | MP0002095_abnormal_skin_pigmentation | 0.42651378 |
| 117 | MP0005379_endocrine/exocrine_gland_phen | 0.41719343 |
| 118 | MP0004142_abnormal_muscle_tone | 0.41152307 |
| 119 | MP0008877_abnormal_DNA_methylation | 0.41097886 |
| 120 | MP0000249_abnormal_blood_vessel | 0.40856494 |
| 121 | MP0005636_abnormal_mineral_homeostasis | 0.40165378 |
| 122 | MP0001119_abnormal_female_reproductive | 0.40088178 |
| 123 | MP0008873_increased_physiological_sensi | 0.39774647 |
| 124 | MP0003195_calcinosis | 0.39605118 |
| 125 | MP0002083_premature_death | 0.39417346 |
| 126 | MP0005253_abnormal_eye_physiology | 0.39275104 |
| 127 | MP0005390_skeleton_phenotype | 0.39228549 |
| 128 | MP0008007_abnormal_cellular_replicative | 0.38231619 |
| 129 | MP0005076_abnormal_cell_differentiation | 0.37615023 |
| 130 | MP0005166_decreased_susceptibility_to | 0.36397171 |
| 131 | MP0001663_abnormal_digestive_system | 0.36152428 |
| 132 | MP0003959_abnormal_lean_body | 0.35513729 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Abnormality of T cell number (HP:0011839) | 8.48287575 |
| 2 | T lymphocytopenia (HP:0005403) | 8.45652591 |
| 3 | Severe combined immunodeficiency (HP:0004430) | 7.39250635 |
| 4 | Stomatitis (HP:0010280) | 7.03355642 |
| 5 | Combined immunodeficiency (HP:0005387) | 6.77972346 |
| 6 | Elevated erythrocyte sedimentation rate (HP:0003565) | 6.25476284 |
| 7 | Abnormality of T cells (HP:0002843) | 5.89298271 |
| 8 | IgG deficiency (HP:0004315) | 5.52282331 |
| 9 | Increased IgM level (HP:0003496) | 5.19020938 |
| 10 | Recurrent bronchitis (HP:0002837) | 5.02134946 |
| 11 | Thyroiditis (HP:0100646) | 4.87890724 |
| 12 | Abnormality of eosinophils (HP:0001879) | 4.81054182 |
| 13 | Myositis (HP:0100614) | 4.63172636 |
| 14 | Abnormality of B cell number (HP:0010975) | 4.44331821 |
| 15 | B lymphocytopenia (HP:0010976) | 4.44331821 |
| 16 | IgM deficiency (HP:0002850) | 4.36082875 |
| 17 | Hypoplasia of the thymus (HP:0000778) | 4.34268710 |
| 18 | Eosinophilia (HP:0001880) | 4.32265450 |
| 19 | Panhypogammaglobulinemia (HP:0003139) | 4.30476180 |
| 20 | Recurrent fungal infections (HP:0002841) | 4.28911741 |
| 21 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 4.21232931 |
| 22 | Lymphopenia (HP:0001888) | 4.21010231 |
| 23 | Optic neuritis (HP:0100653) | 3.94206903 |
| 24 | Retrobulbar optic neuritis (HP:0100654) | 3.94206903 |
| 25 | Leukocytosis (HP:0001974) | 3.91202531 |
| 26 | Recurrent cutaneous fungal infections (HP:0011370) | 3.85598246 |
| 27 | Chronic mucocutaneous candidiasis (HP:0002728) | 3.85598246 |
| 28 | Chronic diarrhea (HP:0002028) | 3.81214788 |
| 29 | Recurrent viral infections (HP:0004429) | 3.80188589 |
| 30 | Eczematoid dermatitis (HP:0000976) | 3.78271855 |
| 31 | Nasal polyposis (HP:0100582) | 3.68246914 |
| 32 | Abnormality of T cell physiology (HP:0011840) | 3.64960364 |
| 33 | Orchitis (HP:0100796) | 3.63895220 |
| 34 | Granulocytopenia (HP:0001913) | 3.60685755 |
| 35 | Aplastic anemia (HP:0001915) | 3.60046482 |
| 36 | Joint swelling (HP:0001386) | 3.54019247 |
| 37 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 3.39093179 |
| 38 | Chronic otitis media (HP:0000389) | 3.33323474 |
| 39 | Abnormality of the nasal mucosa (HP:0000433) | 3.06119269 |
| 40 | Pustule (HP:0200039) | 3.04779190 |
| 41 | Pulmonary infiltrates (HP:0002113) | 3.03460454 |
| 42 | Vasculitis (HP:0002633) | 3.01844855 |
| 43 | Gastrointestinal infarctions (HP:0005244) | 3.00962310 |
| 44 | Meningitis (HP:0001287) | 3.00243680 |
| 45 | Hypergammaglobulinemia (HP:0010702) | 2.97323928 |
| 46 | Hemoptysis (HP:0002105) | 2.95948721 |
| 47 | Autoimmune thrombocytopenia (HP:0001973) | 2.89165110 |
| 48 | Diplopia (HP:0000651) | 2.85765027 |
| 49 | Abnormality of binocular vision (HP:0011514) | 2.85765027 |
| 50 | Recurrent otitis media (HP:0000403) | 2.84680307 |
| 51 | Keratoconjunctivitis sicca (HP:0001097) | 2.83095744 |
| 52 | Lymphoma (HP:0002665) | 2.82127087 |
| 53 | Bronchitis (HP:0012387) | 2.77854906 |
| 54 | Abnormality of the fingertips (HP:0001211) | 2.76580840 |
| 55 | IgA deficiency (HP:0002720) | 2.66086383 |
| 56 | Encephalitis (HP:0002383) | 2.66021213 |
| 57 | Muscle fiber atrophy (HP:0100295) | 2.62902143 |
| 58 | Recurrent sinusitis (HP:0011108) | 2.62238138 |
| 59 | Keratoconjunctivitis (HP:0001096) | 2.55778080 |
| 60 | Mediastinal lymphadenopathy (HP:0100721) | 2.50057270 |
| 61 | Abnormality of macrophages (HP:0004311) | 2.49296241 |
| 62 | Abnormality of male internal genitalia (HP:0000022) | 2.48611610 |
| 63 | Pulmonary fibrosis (HP:0002206) | 2.48603595 |
| 64 | Hypoproteinemia (HP:0003075) | 2.48458018 |
| 65 | Abnormality of the prostate (HP:0008775) | 2.43696073 |
| 66 | Obstructive lung disease (HP:0006536) | 2.41207606 |
| 67 | Chronic obstructive pulmonary disease (HP:0006510) | 2.41207606 |
| 68 | Hemiplegia (HP:0002301) | 2.37599519 |
| 69 | Gangrene (HP:0100758) | 2.35130613 |
| 70 | Arterial thrombosis (HP:0004420) | 2.33807182 |
| 71 | Agammaglobulinemia (HP:0004432) | 2.29092107 |
| 72 | Congenital stationary night blindness (HP:0007642) | 2.29067048 |
| 73 | Pulmonary embolism (HP:0002204) | 2.22183412 |
| 74 | Hypoalbuminemia (HP:0003073) | 2.20377302 |
| 75 | Abnormal albumin level (HP:0012116) | 2.20377302 |
| 76 | Pancytopenia (HP:0001876) | 2.15635140 |
| 77 | Papilledema (HP:0001085) | 2.12246913 |
| 78 | Recurrent skin infections (HP:0001581) | 2.11642159 |
| 79 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 2.11399942 |
| 80 | * Autoimmune hemolytic anemia (HP:0001890) | 2.10624807 |
| 81 | Acute hepatic failure (HP:0006554) | 2.08198767 |
| 82 | Recurrent abscess formation (HP:0002722) | 2.05023710 |
| 83 | Recurrent bacterial skin infections (HP:0005406) | 2.04839412 |
| 84 | Aplasia/Hypoplasia of the thymus (HP:0010515) | 2.04788920 |
| 85 | Skin rash (HP:0000988) | 2.02665856 |
| 86 | Ureteral stenosis (HP:0000071) | 2.00154522 |
| 87 | Genetic anticipation (HP:0003743) | 1.98769509 |
| 88 | Anorexia (HP:0002039) | 1.98194017 |
| 89 | Reduced subcutaneous adipose tissue (HP:0003758) | 1.95564549 |
| 90 | Basal cell carcinoma (HP:0002671) | 1.94213368 |
| 91 | Spontaneous hematomas (HP:0007420) | 1.89644790 |
| 92 | Verrucae (HP:0200043) | 1.88761102 |
| 93 | Papilloma (HP:0012740) | 1.88761102 |
| 94 | Premature graying of hair (HP:0002216) | 1.83506972 |
| 95 | Increased IgE level (HP:0003212) | 1.82897942 |
| 96 | Prostate neoplasm (HP:0100787) | 1.82877423 |
| 97 | Abnormality of the pericardium (HP:0001697) | 1.82671780 |
| 98 | 3-Methylglutaconic aciduria (HP:0003535) | 1.81990757 |
| 99 | Chest pain (HP:0100749) | 1.80146752 |
| 100 | Inflammation of the large intestine (HP:0002037) | 1.80067649 |
| 101 | Amyotrophic lateral sclerosis (HP:0007354) | 1.79726292 |
| 102 | Alveolar cell carcinoma (HP:0006519) | 1.79507699 |
| 103 | Ureteral obstruction (HP:0006000) | 1.79446055 |
| 104 | Polyneuropathy (HP:0001271) | 1.78846233 |
| 105 | Keratitis (HP:0000491) | 1.77322130 |
| 106 | Renal cortical cysts (HP:0000803) | 1.77006669 |
| 107 | Thrombocytosis (HP:0001894) | 1.76363187 |
| 108 | Amaurosis fugax (HP:0100576) | 1.75845798 |
| 109 | Epistaxis (HP:0000421) | 1.75218116 |
| 110 | Gastrointestinal inflammation (HP:0004386) | 1.73995390 |
| 111 | Abnormality of the pleura (HP:0002103) | 1.73070505 |
| 112 | Abnormal rod and cone electroretinograms (HP:0008323) | 1.73009148 |
| 113 | Arthralgia (HP:0002829) | 1.73005115 |
| 114 | Cheilitis (HP:0100825) | 1.71083619 |
| 115 | Glomerulopathy (HP:0100820) | 1.69767003 |
| 116 | Abnormal number of erythroid precursors (HP:0012131) | 1.65973598 |
| 117 | Type 2 muscle fiber atrophy (HP:0003554) | 1.65774971 |
| 118 | Bronchiectasis (HP:0002110) | 1.65288936 |
| 119 | Chronic sinusitis (HP:0011109) | 1.64717049 |
| 120 | Stomach cancer (HP:0012126) | 1.64505013 |
| 121 | Hypochromic anemia (HP:0001931) | 1.63798863 |
| 122 | Abnormality of cells of the erythroid lineage (HP:0012130) | 1.63767194 |
| 123 | Gingivitis (HP:0000230) | 1.63364009 |
| 124 | Entropion (HP:0000621) | 1.61918502 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TXK | 6.71420553 |
| 2 | MAP4K1 | 5.35180695 |
| 3 | ZAP70 | 3.80557005 |
| 4 | ITK | 3.52054119 |
| 5 | FGFR4 | 3.02858138 |
| 6 | TESK2 | 2.87322885 |
| 7 | KDR | 2.81122579 |
| 8 | IKBKE | 2.79624342 |
| 9 | TAOK3 | 2.37630253 |
| 10 | JAK3 | 2.31186762 |
| 11 | LCK | 2.19472593 |
| 12 | MST4 | 2.17074964 |
| 13 | GRK6 | 2.15518856 |
| 14 | TYK2 | 2.14625293 |
| 15 | STK10 | 2.11762979 |
| 16 | NLK | 1.92304687 |
| 17 | TBK1 | 1.91818399 |
| 18 | JAK1 | 1.88336503 |
| 19 | ADRBK2 | 1.79767789 |
| 20 | FGFR3 | 1.78117001 |
| 21 | CSK | 1.75355543 |
| 22 | TEC | 1.72812756 |
| 23 | CAMKK2 | 1.72086515 |
| 24 | MAP3K14 | 1.70538185 |
| 25 | SYK | 1.68468842 |
| 26 | FRK | 1.68362022 |
| 27 | MAP3K12 | 1.67552856 |
| 28 | HCK | 1.52012093 |
| 29 | BRD4 | 1.50807712 |
| 30 | BLK | 1.45241730 |
| 31 | GRK7 | 1.44690577 |
| 32 | NME2 | 1.37173014 |
| 33 | BTK | 1.36489745 |
| 34 | SIK3 | 1.34921818 |
| 35 | EEF2K | 1.33198262 |
| 36 | NUAK1 | 1.25236218 |
| 37 | MAP3K10 | 1.16913737 |
| 38 | CLK1 | 1.15561343 |
| 39 | RIPK4 | 1.14322644 |
| 40 | TNK2 | 1.14237046 |
| 41 | PRKCQ | 1.14120502 |
| 42 | PRKCH | 1.09544193 |
| 43 | CDK3 | 1.05942308 |
| 44 | TLK1 | 1.04688175 |
| 45 | BUB1 | 1.03748110 |
| 46 | PIK3CA | 1.00497726 |
| 47 | TESK1 | 1.00401867 |
| 48 | GRK1 | 0.99762953 |
| 49 | LRRK2 | 0.98691950 |
| 50 | CDK4 | 0.95772253 |
| 51 | ZAK | 0.94941585 |
| 52 | MAP3K13 | 0.93181673 |
| 53 | KIT | 0.93117666 |
| 54 | MAPKAPK3 | 0.93030984 |
| 55 | PIK3CG | 0.92296577 |
| 56 | LYN | 0.91348995 |
| 57 | CAMKK1 | 0.85754208 |
| 58 | IKBKB | 0.83203620 |
| 59 | IRAK4 | 0.73401172 |
| 60 | PIM1 | 0.71101597 |
| 61 | FGFR1 | 0.70978648 |
| 62 | MAP3K7 | 0.70178075 |
| 63 | BMPR1B | 0.69914866 |
| 64 | TRIM28 | 0.68528593 |
| 65 | INSR | 0.68340914 |
| 66 | EIF2AK1 | 0.67798246 |
| 67 | BCKDK | 0.67284837 |
| 68 | VRK1 | 0.64733038 |
| 69 | CDK8 | 0.62948561 |
| 70 | JAK2 | 0.60036065 |
| 71 | PDGFRB | 0.59499246 |
| 72 | WNK4 | 0.57716491 |
| 73 | FGFR2 | 0.54407368 |
| 74 | BCR | 0.54243632 |
| 75 | CDK9 | 0.53288349 |
| 76 | HIPK2 | 0.53067737 |
| 77 | * FYN | 0.52952397 |
| 78 | TYRO3 | 0.51233637 |
| 79 | FES | 0.50833196 |
| 80 | AKT3 | 0.50391263 |
| 81 | CHUK | 0.50364190 |
| 82 | TAOK1 | 0.47322184 |
| 83 | STK4 | 0.47167822 |
| 84 | MAP4K2 | 0.46974359 |
| 85 | TSSK6 | 0.45056616 |
| 86 | CDK6 | 0.44472053 |
| 87 | PRKD2 | 0.41602462 |
| 88 | MAPK11 | 0.39862715 |
| 89 | TRPM7 | 0.39802214 |
| 90 | MARK2 | 0.37678624 |
| 91 | MAPK13 | 0.37132941 |
| 92 | RPS6KA4 | 0.36959366 |
| 93 | DYRK1B | 0.36146708 |
| 94 | RPS6KB2 | 0.35506506 |
| 95 | GRK5 | 0.33755858 |
| 96 | MYLK | 0.33262311 |
| 97 | RIPK1 | 0.32721949 |
| 98 | SIK2 | 0.30799912 |
| 99 | MAP2K6 | 0.30075953 |
| 100 | TGFBR2 | 0.29076640 |
| 101 | MAPK7 | 0.27422334 |
| 102 | INSRR | 0.26721259 |
| 103 | PDK1 | 0.26432799 |
| 104 | AURKB | 0.25256342 |
| 105 | DAPK1 | 0.25152731 |
| 106 | CSF1R | 0.24896488 |
| 107 | LIMK1 | 0.24561456 |
| 108 | CDC7 | 0.23615030 |
| 109 | ERBB3 | 0.23136314 |
| 110 | NEK2 | 0.23020077 |
| 111 | MAP3K11 | 0.22760102 |
| 112 | NEK6 | 0.22240777 |
| 113 | BMPR2 | 0.22208313 |
| 114 | PKN2 | 0.21805224 |
| 115 | IRAK1 | 0.21646992 |
| 116 | VRK2 | 0.21079298 |
| 117 | ILK | 0.21013739 |
| 118 | SRC | 0.20631351 |
| 119 | MARK3 | 0.20546930 |
| 120 | MAPK3 | 0.20390893 |
| 121 | ACVR1B | 0.20123254 |
| 122 | PINK1 | 0.19878882 |
| 123 | * PRKCA | 0.19177589 |
| 124 | EIF2AK3 | 0.18992268 |
| 125 | ABL1 | 0.17953981 |
| 126 | PASK | 0.17301518 |
| 127 | * IGF1R | 0.16762384 |
| 128 | RPS6KB1 | 0.16277677 |
| 129 | CDK12 | 0.15812548 |
| 130 | PRKCD | 0.14941284 |
| 131 | CSNK1D | 0.14705286 |
| 132 | DYRK3 | 0.14500040 |
| 133 | NTRK2 | 0.14151219 |
| 134 | RPS6KA5 | 0.13709744 |
| 135 | SRPK1 | 0.13696494 |
| 136 | MAPKAPK2 | 0.13442120 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary immunodeficiency_Homo sapiens_hsa05340 | 7.15634751 |
| 2 | Graft-versus-host disease_Homo sapiens_hsa05332 | 5.48852219 |
| 3 | * T cell receptor signaling pathway_Homo sapiens_hsa04660 | 4.00666234 |
| 4 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 3.99064059 |
| 5 | Antigen processing and presentation_Homo sapiens_hsa04612 | 3.57394162 |
| 6 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 2.95584360 |
| 7 | Allograft rejection_Homo sapiens_hsa05330 | 2.92315510 |
| 8 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 2.74488065 |
| 9 | * Measles_Homo sapiens_hsa05162 | 2.71035267 |
| 10 | * Hematopoietic cell lineage_Homo sapiens_hsa04640 | 2.32403395 |
| 11 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.23235830 |
| 12 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 2.21373502 |
| 13 | Viral myocarditis_Homo sapiens_hsa05416 | 1.74200181 |
| 14 | Ribosome_Homo sapiens_hsa03010 | 1.68133796 |
| 15 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.55983678 |
| 16 | Leishmaniasis_Homo sapiens_hsa05140 | 1.48379235 |
| 17 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 1.45618926 |
| 18 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.45104918 |
| 19 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.43208721 |
| 20 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.40680084 |
| 21 | Asthma_Homo sapiens_hsa05310 | 1.35797836 |
| 22 | Non-homologous end-joining_Homo sapiens_hsa03450 | 1.35592452 |
| 23 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.30030341 |
| 24 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.22602389 |
| 25 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.22453462 |
| 26 | * Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.19022257 |
| 27 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.13252027 |
| 28 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.10108824 |
| 29 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.04258872 |
| 30 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 1.03702328 |
| 31 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.03292350 |
| 32 | * HTLV-I infection_Homo sapiens_hsa05166 | 1.02638386 |
| 33 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 1.00044485 |
| 34 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.98115115 |
| 35 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.97287275 |
| 36 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.95243991 |
| 37 | Hepatitis B_Homo sapiens_hsa05161 | 0.92765848 |
| 38 | Shigellosis_Homo sapiens_hsa05131 | 0.91930587 |
| 39 | Phototransduction_Homo sapiens_hsa04744 | 0.89421757 |
| 40 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.89226427 |
| 41 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.86579420 |
| 42 | Spliceosome_Homo sapiens_hsa03040 | 0.86173203 |
| 43 | Apoptosis_Homo sapiens_hsa04210 | 0.82722590 |
| 44 | Malaria_Homo sapiens_hsa05144 | 0.77717696 |
| 45 | Influenza A_Homo sapiens_hsa05164 | 0.77682675 |
| 46 | Colorectal cancer_Homo sapiens_hsa05210 | 0.74935442 |
| 47 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.72693042 |
| 48 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.70923351 |
| 49 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.70728616 |
| 50 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.70306012 |
| 51 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.69744676 |
| 52 | Parkinsons disease_Homo sapiens_hsa05012 | 0.68133211 |
| 53 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.66799600 |
| 54 | DNA replication_Homo sapiens_hsa03030 | 0.65383228 |
| 55 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.64635478 |
| 56 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.64308087 |
| 57 | Proteasome_Homo sapiens_hsa03050 | 0.64145929 |
| 58 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.64094658 |
| 59 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.63967146 |
| 60 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.62838737 |
| 61 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.62643708 |
| 62 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.61808189 |
| 63 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.61525278 |
| 64 | Platelet activation_Homo sapiens_hsa04611 | 0.60468975 |
| 65 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.59003534 |
| 66 | Hepatitis C_Homo sapiens_hsa05160 | 0.54501559 |
| 67 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.52590910 |
| 68 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.51811241 |
| 69 | Salmonella infection_Homo sapiens_hsa05132 | 0.50893621 |
| 70 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.50615100 |
| 71 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.49930440 |
| 72 | Legionellosis_Homo sapiens_hsa05134 | 0.47932656 |
| 73 | Thyroid cancer_Homo sapiens_hsa05216 | 0.45692185 |
| 74 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.44262046 |
| 75 | Olfactory transduction_Homo sapiens_hsa04740 | 0.43954895 |
| 76 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.43943960 |
| 77 | Adherens junction_Homo sapiens_hsa04520 | 0.42754144 |
| 78 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.42559658 |
| 79 | Mismatch repair_Homo sapiens_hsa03430 | 0.41827374 |
| 80 | Basal transcription factors_Homo sapiens_hsa03022 | 0.41052310 |
| 81 | Alzheimers disease_Homo sapiens_hsa05010 | 0.39343961 |
| 82 | Nucleotide excision repair_Homo sapiens_hsa03420 | 0.39247364 |
| 83 | Tuberculosis_Homo sapiens_hsa05152 | 0.38134844 |
| 84 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.37011361 |
| 85 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.35638724 |
| 86 | Endocytosis_Homo sapiens_hsa04144 | 0.35484701 |
| 87 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 0.34962360 |
| 88 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.33863554 |
| 89 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.32846444 |
| 90 | RNA degradation_Homo sapiens_hsa03018 | 0.32271711 |
| 91 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.31702699 |
| 92 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.31384326 |
| 93 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.29839681 |
| 94 | Base excision repair_Homo sapiens_hsa03410 | 0.27724432 |
| 95 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.26777995 |
| 96 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.26696398 |
| 97 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.26336730 |
| 98 | Peroxisome_Homo sapiens_hsa04146 | 0.25572906 |
| 99 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.25266751 |
| 100 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.25024265 |
| 101 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.24996576 |
| 102 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.24736914 |
| 103 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.24437710 |
| 104 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.21830740 |
| 105 | Pertussis_Homo sapiens_hsa05133 | 0.21244292 |
| 106 | Morphine addiction_Homo sapiens_hsa05032 | 0.20655364 |
| 107 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.19890447 |
| 108 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.19772369 |
| 109 | Protein export_Homo sapiens_hsa03060 | 0.19237936 |
| 110 | Circadian rhythm_Homo sapiens_hsa04710 | 0.18828476 |
| 111 | ABC transporters_Homo sapiens_hsa02010 | 0.18734035 |
| 112 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.18295350 |
| 113 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.16151001 |
| 114 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.14673615 |
| 115 | RNA polymerase_Homo sapiens_hsa03020 | 0.14312667 |
| 116 | Huntingtons disease_Homo sapiens_hsa05016 | 0.13337942 |
| 117 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.12608621 |
| 118 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.11899156 |
| 119 | Pathways in cancer_Homo sapiens_hsa05200 | 0.11373926 |
| 120 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.11358817 |
| 121 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.10679841 |
| 122 | Cell cycle_Homo sapiens_hsa04110 | 0.09760928 |
| 123 | Retinol metabolism_Homo sapiens_hsa00830 | 0.09465969 |
| 124 | Endometrial cancer_Homo sapiens_hsa05213 | 0.09382002 |
| 125 | Other glycan degradation_Homo sapiens_hsa00511 | 0.09312010 |
| 126 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 0.08831249 |
| 127 | Prostate cancer_Homo sapiens_hsa05215 | 0.07384751 |
| 128 | Renin secretion_Homo sapiens_hsa04924 | 0.06952977 |
| 129 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.06940053 |
| 130 | Taste transduction_Homo sapiens_hsa04742 | 0.06851832 |
| 131 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.06688835 |
| 132 | Homologous recombination_Homo sapiens_hsa03440 | 0.06619166 |
| 133 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.06346594 |
| 134 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.06029081 |

